Cited by 206Alzheimer's disease research and treatmentsMitochondrial Function and PathologyMicrotubule and mitosis dynamics

Regulation of Mitochondrial Transport and Inter-Microtubule Spacing by Tau Phosphorylation at the Sites Hyperphosphorylated in Alzheimer's Disease

Open access
Shahpasand, Kourosh, Uemura, Isao, Saito, Taro, Asano, Tsunaki, Hata, Kenji, Shibata, Keitaro, Toyoshima, Yoko, Hasegawa, Masato +1 more·2012·The Journal of Neuroscience

Abstract

The microtubule-associated protein Tau is a major component of the neurofibrillary tangles that serve as a neuropathological hallmark of Alzheimer's disease. Tau is a substrate for protein phosphorylation at multiple sites and occurs in tangles in a hyperphosphorylated state. However, the physiological functions of Tau phosphorylation or how it may contribute mechanistically to Alzheimer's pathophysiology are not completely understood. Here, we examined the function of human Tau phosphorylation at three sites, Ser199, Ser202, and Thr205, which together comprise the AT8 sites that mark abnormal phosphorylation in Alzheimer's disease. Overexpression of wild-type Tau or mutated forms in which these sites had been changed to either unphosphorylatable alanines or phosphomimetic aspartates inhibited mitochondrial movement in the neurite processes of PC12 cells as well as the axons of mouse brain cortical neurons. However, the greatest effects on mitochondrial translocation were induced by phosphomimetic mutations. These mutations also caused expansion of the space between microtubules in cultured cells when membrane tension was reduced by disrupting actin filaments. Thus, Tau phosphorylation at the AT8 sites may have meaningful effects on mitochondrial movement, likely by controlling microtubule spacing. Hyperphosphorylation of the AT8 sites may contribute to axonal degeneration by disrupting mitochondrial transport in Alzheimer's disease.

AI snapshot

Written from the paper’s full text.

TL;DR

Tau phosphorylation at the Alzheimer’s disease–associated AT8 sites (Ser199/Ser202/Thr205) more strongly inhibits mitochondrial movement than wild-type or nonphosphorylatable Tau. The phosphomimetic Tau 3D also expands inter-microtubule spacing under reduced membrane tension, suggesting a mechanism linking AT8 phosphorylation to impaired axonal mitochondrial transport.

Key findings

  • In NGF-treated PC12 cell neurites, the stationary mitochondrial fraction was 23.0% in controls, 47.6% with Tau WT, 44.1% with Tau 3A, and 61.3% with phosphomimetic Tau 3D.
  • In cultured mouse cortical neuron axons, stationary mitochondria were 31.6% in controls, 48.5% with Tau WT, 46.6% with Tau 3A, and 64.4% with Tau 3D.
  • In latrunculin B–treated Sf9 cell processes, mean inter-microtubule distances were 26.8 ± 2.7 nm for Tau WT, 27.2 ± 2.0 nm for Tau 3A, and 37.1 ± 2.3 nm for Tau 3D.
  • Tau did not alter kinesin head-domain binding to microtubules in vitro, and in PC12 neurites Tau overexpression reduced inter-MT distances to ~33–34 nm without significant differences among WT, 3A, and 3D.

Methods

  • The longest human Tau was mutated at Ser199, Ser202, and Thr205 to nonphosphorylatable alanines (3A) or phosphomimetic aspartates (3D); WT, 3A, and 3D were expressed in PC12 cells, mouse embryonic cortical neurons, COS-7 cells, and Sf9 cells.
  • Mitochondrial movement was imaged with Mito-GFP at 5 s intervals over 300 s in PC12 neurites and cortical neuron axons; inter-MT distances were measured by electron microscopy, including Sf9 cells treated with latrunculin B to disrupt actin filaments.
  • In vitro assays examined Tau phosphorylation by Cdk5-p25, Tau binding to microtubules, and kinesin motor-domain binding to microtubules; statistics used one-way ANOVA with Holm’s test and ANCOVA.

Limitations

  • The paper states that untreated Sf9 cells formed only a small number of processes, so the number of inter-MT distances counted was not sufficient; latrunculin B was used to increase process formation.
  • The paper notes that in matured or aged neurons, Tau may not be the only space-making protein affecting mitochondrial movement, and that neurofilament tail domains may also contribute; the phosphorylation-dependent tunnel-opening/closing idea is described as a working hypothesis to be explored further.
  • Evident from the text: the study relies on cell-culture overexpression systems and phosphomimetic mutants rather than human AD tissue or in vivo models, so the 3D mutant may not fully replicate native phosphorylation effects.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.5927-11.2012

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

23 of 54 cited sources checked · 7 supported · 0 flagged · accuracy not yet measured

  • Findingcitation

    Cdk5 phosphorylates Tau at the sites recognized by AT8 (Ser199, Ser202, and Thr205).

    “confirming that Cdk5 indeed phosphorylated the sites recognized by AT8 (Takahashi et al., 2003) and that these phosphorylation sites were disrupted in 3A and 3D constructs.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Takahashi et al., 2003 source

      The Results and Discussion report that Cdk5 is involved in tau phosphorylation detected by AT-8, particularly at Ser-202 and Thr-205 during brain development. The Chemicals and Antibodies section defines AT-8 recognition by phosphorylation at those two sites, not Ser-199; our copy therefore does not support including Ser-199 among the AT-8-recognized sites. Page numbers were not available in our copy. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
  • Premisecitation

    Overexpression of Tau inhibits mitochondrial transport in various cells.

    “Overexpression of Tau inhibits mitochondrial transport in various cells (Ebneth et al., 1998;Trinczek et al., 1999;Stamer et al., 2002;Dixit et al., 2008;Stoothoff et al., 2009;Vossel et al., 2010).”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites Ebneth et al., 1998 source
    • cites Trinczek et al., 1999 source
    • cites Stamer et al., 2002 source
  • Findingcitation

    Overexpression of Tau WT, 3A, or 3D reduced anterograde movement of mitochondria in PC12 cells and cortical neurons.

    “Overexpression of either Tau WT, 3A, or 3D reduced anterograde movement of mitochondria in PC12 cells and cortical neurons, as reported (Mandelkow et al., 2004;Hollenbeck and Saxton, 2005;Dixit et al., 2008).”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites Mandelkow et al., 2004 source

      The Results (Fig. 5; page unavailable) show that tau expression reduced anterograde mitochondrial movement in retinal ganglion cell axons, and Fig. 7 reports transport inhibition by a non-phosphorylatable tau mutant. The paper does not establish the stated effect for Tau 3D or in PC12 cells and cortical neurons; its experiments here use retinal ganglion cells and a KXGA mutant. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites Hollenbeck and Saxton, 2005 source
    • cites Dixit et al., 2008 source
  • Premisecitation

    Tau overexpression inhibits mitochondrial movement in various cell types.

    “Tau overexpression inhibits mitochondrial movement in various cell types (Ebneth et al., 1998;Trinczek et al., 1999;Stamer et al., 2002;Dixit et al., 2008;Stoothoff et al., 2009;Vossel et al., 2010).”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites Ebneth et al., 1998 source
    • cites Trinczek et al., 1999 source
    • cites Stamer et al., 2002 source
  • Interpretationreasoning

    Limited spacing between MTs may block mitochondrial movement in neuritic processes such as axons and dendrites.

    “Considering that mitochondria would be transported within MT bundles in cultured neurons (Yu and Baas, 1994;Rochlin et al., 1996), limited spacing between MTs may block mitochondrial movement in neuritic processes such as axon and dendrites.”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites Yu and Baas, 1994 source
    • cites Rochlin et al., 1996 source

      The Additional information section says microtubules could provide a scaffold along which endoplasmic reticulum and other axoplasmic elements advance. It does not specifically describe mitochondrial transport within microtubule bundles. The suggestion that limited spacing may block movement is the citing authors’ inference, not a finding attributed to this source. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • May combine two claims. 30
  • Classified as probably not a substantial claim. 12
  • The quote only partly states this claim. 5
  • May combine two claims.

    Interpretationcitation

    Hyperphosphorylation of the tail domains would increase the inter-NF distances to expand the NF domain in axons, giving higher pressure to the MT domain.

    “Hyperphosphorylation of the tail domains would increase the inter-NF distances to expand the NF domain in axons (Kumar et al., 2002;Kanungo et al., 2011), giving higher pressure to the MT domain.”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites Kumar et al., 2002 source

      The Discussion reports that increased sidearm phosphorylation expands the sidearm brush and regulates spacing between neurofilaments. It does not establish that this expands a distinct NF domain in the axon. The subsequent suggestion of higher pressure on the MT domain is not addressed by the paper and appears to be the citing authors’ inference. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites Kanungo et al., 2011

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Hyperphosphorylation of Tau is linked to neurodegeneration, with phosphorylation of more than 20 sites shown in degenerated brains of Alzheimer's patients.

    “However, hyperphosphorylation is linked to neurodegeneration with phosphorylation of more than 20 sites shown in the degenerated brains of Alzheimer's patients (Watanabe et al., 1993;Morishima-Kawashima et al., 1995;Stoothoff and Johnson, 2005).”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites Watanabe et al., 1993 source
    • cites Morishima-Kawashima et al., 1995 source

      The opening section reports abnormal phosphorylation of PHF-tau in Alzheimer’s disease and identifies 19 sites, not more than 20. It also describes neurofibrillary tangles as closely related to neuronal loss, while the Discussion presents a link between abnormal tau phosphorylation and neuronal degeneration as a possibility rather than an established finding. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
    • cites Stoothoff and Johnson, 2005

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Detection by AT8 is commonly used as a marker of abnormal phosphorylation in brains of Alzheimer's patients.

    “their detection by this antibody is commonly used as a marker of abnormal phosphorylation in brains of Alzheimer's patients.”
    Quote in the paperNot a substantial claim1 of 3 sources checked
    • cites Goedert et al., 1995 source
    • cites Wang et al., 2006 source

      The Abstract links Alzheimer’s disease to tau hyperphosphorylation, but it does not identify AT8 or describe its use as a marker in patients’ brains. Searches for AT8 and for antibody-based detection found no passage addressing that point. (LLM, conf=0.74)

      Experimental — accuracy not yet measured
    • cites Hanger et al., 2009 source
  • May combine two claims.

    Premisecitation

    Phosphorylation at the AT8 sites may extend the projection domain outwards from the surface of microtubules and affect mitochondrial transport.

    “Phosphorylation at these sites may extend the projection domain outwards from the surface of MTs (Jeganathan et al., 2008) and affect mitochondrial transport (Mukhopadhyay and Hoh, 2001;Jeganathan et al., 2008;Shahpasand et al., 2008).”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites Jeganathan et al., 2008 source

      The Results passage (Fig. 2C–D; page unavailable) reports that an AT8 phosphorylation mimic makes tau’s N-terminal domain swing away from its C-terminal domain. The introductory passage says the N-terminal domain projects away from the microtubule surface, but the study does not show that AT8 phosphorylation extends it farther from that surface. It discusses microtubule-based organelle transport generally, not an effect on mitochondrial transport. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
    • cites Mukhopadhyay and Hoh, 2001 source

      The citation to Mukhopadhyay and Hoh is attached to the mitochondrial-transport clause. In Results and discussion (page unavailable), the paper says MAPs may regulate motor-protein interactions and reports that tau affects motor attachment and detachment, but not transport speed. It does not address mitochondrial transport or link phosphorylation at AT8 sites to a transport effect. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
    • cites Shahpasand et al., 2008 source
  • May combine two claims.

    Premisecitation

    The AT8 sites (Ser199/Ser202/Thr205) are physiological phosphorylation sites and markers of hyperphosphorylation in Alzheimer's disease.

    “The AT8 sites are not only physiological phosphorylation sites (Kimura et al., 2007;Verwer et al., 2007) but also markers of hyperphosphorylation in Alzheimer's disease (Plattner et al., 2006).”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites Kimura et al., 2007 source

      The Results section (page unavailable) reports AT8 phosphorylation in both adult and aged mice expressing wild-type human tau, without an age-related increase. This supports the narrower point that AT8 phosphorylation can occur without age-related hyperphosphorylation, but the study does not establish that the sites are physiological in normal animals; it also identifies the AT8 sites as Ser202 and Ser205, not Ser199/Ser202/Thr205. The Alzheimer's disease marker claim is attributed to Plattner et al., not Kimura et al., in the citing sentence. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites Verwer et al., 2007 source
    • cites Plattner et al., 2006 source
  • May combine two claims.

    Premisecitation

    The AT8 sites are physiological sites for phosphorylation, but they are not always phosphorylated.

    “The AT8 sites are physiological sites for phosphorylation, but they are not always phosphorylated (Kimura et al., 2007;Verwer et al., 2007).”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites Kimura et al., 2007 source

      The section on PHF1-site phosphorylation identifies AT8 as recognizing tau phosphorylated at Ser202 and Ser205, and reports AT8 immunoreactivity in the studied mice. The Discussion says AT8-site phosphorylation did not increase with aging in those mice, but it does not establish that phosphorylation at these sites is physiological or that the sites are sometimes unphosphorylated. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites Verwer et al., 2007 source
  • May combine two claims.

    Premisecitation

    The C-terminal tail domains of neurofilament M and H subunits extrude outward from core filaments, as does the projection domain of Tau, to make spaces between neurofilaments.

    “The C-terminal tail domains of neurofilament M and H subunits extrude outward from core filaments, as does the projection domain of Tau, to make spaces between neurofilaments (NFs) (Hisanaga and Hirokawa, 1989).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Hisanaga and Hirokawa, 1989 source

      The section “Structure of the projections of control and dephosphorylated NFs” (page unavailable) describes projections extending from NF core filaments, and the Discussion describes cross-bridges between NFs that seem to comprise NF-H and NF-M tail domains. The copy does not discuss Tau’s projection domain or establish that these projections create the spaces between neurofilaments. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    When Tau is overexpressed in cortical neurons, tubulin synthesis is upregulated and MTs become more numerous and densely packed, resulting in inhibition of mitochondrial movement.

    “When Tau is overexpressed in cortical neurons, tubulin synthesis is upregulated and MTs become more numerous and densely packed, resulting in inhibition of mitochondrial movement.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Thies and Mandelkow, 2007 source

      The Microtubule bundling section reports increased tubulin production and denser, more numerous microtubules after tau transfection; the mitochondrial-movement section reports strongly inhibited movement. However, Materials and Methods identifies the cells as hippocampal, not cortical, neurons, and the Discussion describes increased microtubule density and bundling as a possible contributor to the transport defect rather than its established sole cause. Page numbers were not available in our copy. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingown data

    Tau 3A and 3D constructs are not phosphorylated at the AT8 sites.

    “Phosphorylated Tau WT was immunoreactive to AT8, whereas phosphorylated Tau 3A and 3D were not (Fig. 1 B)”
    • Also stated in: § Phosphorylation of Tau mutants and their binding to MTs · boosted
      “Immunodetection of Tau WT but not 3A nor 3D clearly demonstrated that Tau WT was phosphorylated at the AT8 recognition sites in COS-7 cells (Fig. 1C, middle).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In PC12 cells, the stationary phase of mitochondria was 23.0% in control, 47.6% in Tau WT, 44.1% in Tau 3A, and 61.3% in Tau 3D.

    “The ratio of stationary phase was 23.0% in control PC12 cells but 47.6% in cells expressing Tau WT and 44.1% for 3A; for 3D, however, the percentage was higher still, 61.3% (Fig. 4B).”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    Expression levels of Tau WT, 3A, and 3D were almost similar in PC12 cells and cultured neurons when 2.5 μg plasmids were used.

    “Expression levels were almost similar among Tau WT, 3A, and 3D constructs (Fig. 3 B, C).”
    • Also stated in: § Expression of Tau constructs in PC12 cells and cultured cortical neurons · plain
      “When 2.5 g of plasmids were used, the fluorescent intensities were ϳ1.7 and ϳ1.5 fold of untransfected PC12 cells (Fig. 3B) and cultured neurons (Fig. 3C), respectively.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The inter-MT distance was the same (15-25 nm) in MT bundles formed by Tau WT, 3A, and 3D in Sf9 cell processes, but it was expanded to 35-45 nm in processes expressing Tau 3D when actin filaments were disrupted by latrunculin B.

    “The inter-MT distance was the same (15-25 nm) in MT bundles formed by Tau WT, 3A, and 3D in Sf9 cell processes, but it was expanded to 35-45 nm in processes expressing Tau 3D when actin filaments were disrupted by latrunculin B.”
    • Also stated in: § Discussion · plain
      “The mean distance was 15.7 Ϯ 2.2 nm for Tau WT (n ϭ 30), 17.5 Ϯ 2.7 nm for Tau 3A (n ϭ 27), and 16.3 Ϯ 2.2 nm for Tau 3D (n ϭ 28).”
    • Also stated in: § Discussion · plain
      “The mean distance was 26.8 Ϯ 2.7 nm for Tau WT (n ϭ 60), 27.2 Ϯ 2.0 nm for Tau 3A (n ϭ 80), and 37.1 Ϯ 2.3 nm for Tau 3D (n ϭ 75).”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    The ratio of mitochondria moving anterogradely and retrogradely was not different among Tau WT, Tau 3A, and Tau 3D in cortical neurons.

    “However, the ratio of mitochondria moving anterogradely and retrogradely was not different among three Tau constructs, indicating that phosphorylation at the AT8 sites does not affect the direction of mitochondrial movements.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In cortical neuron axons, the stationary phase of mitochondria was 31.6% in control, 48.5% in Tau WT, 46.6% in Tau 3A, and 64.4% in Tau 3D.

    “The duration of stationary phase was 31.6% in control neurons, which was higher than that observed in PC12 cells, consistent with a previous report (Morel et al., 2010).A significant increase in stationary phase was observed after transfection with Tau WT (48.5%) or 3A (46.6%); however, a higher stationary state (64.4%) was caused by Tau 3D (Fig. 5B).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Morel et al., 2010 source
  • May combine two claims.

    Findingown data

    In vitro MT pellets, the mean inter-MT distance was 11.7 ± 1.7 nm for Tau WT, 11.8 ± 2.1 nm for Tau 3A, and 11.9 ± 1.6 nm for Tau 3D.

    “The mean distance was 11.7 Ϯ 1.7 nm for Tau WT (n ϭ 48), 11.8 Ϯ 2.1 nm for Tau 3A (n ϭ 51), and 11.9 Ϯ 1.6 nm for Tau 3D (n ϭ 69).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Transfection with less than 2 μg Tau plasmid did not significantly affect mitochondrial movement, while more than 3 μg had a substantial and similar effect for all Tau constructs.

    “While transfection with less than 2 g did not significantly affect mitochondrial movement, more than 3 g had a substantial (and similar) effect for all Tau constructs (data not shown).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The ratio of anterogradely moving duration to total moving period was significantly different between control and Tau-overexpressing neurons (p < 0.01) but not different between the three Tau constructs (p = 0.55).

    “The ratio was significantly different between control and Tau-overexpressing neurons (p Ͻ 0.01) but was not different between three Tau constructs(pϭ0.55).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Tau overexpression increased the number of MTs and reduced the inter-MT spaces in neurites of PC12 cells.

    “We observed here that Tau overexpression increased the number of MTs and reduced the inter-MT spaces in neurites of PC12 cells.”
    • Also stated in: § Discussion · plain
      “The mean distance was 45.1 Ϯ 2.2 (n ϭ 54) for control PC12 cells and 33.1 Ϯ 2.4 nm (n ϭ 49), 34.1 Ϯ 2.6 nm (n ϭ 44), and 34.19 Ϯ 2.8 nm (n ϭ 62) for PC12 cells overexpressing Tau WT, 3A, and 3D, respectively.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Findingnone given

    Tau 3A and 3D have similar phosphorylation profiles at other sites.

    “Because Tau 3A and 3D have similar phosphorylation profiles at other sites”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In PC12 cell neurites, the mean inter-MT distance was 45.1 ± 2.2 nm for control and 33.1 ± 2.4 nm, 34.1 ± 2.6 nm, and 34.19 ± 2.8 nm for Tau WT, 3A, and 3D, respectively.

    “The mean distance was 45.1 Ϯ 2.2 (n ϭ 54) for control PC12 cells and 33.1 Ϯ 2.4 nm (n ϭ 49), 34.1 Ϯ 2.6 nm (n ϭ 44), and 34.19 Ϯ 2.8 nm (n ϭ 62) for PC12 cells overexpressing Tau WT, 3A, and 3D, respectively.”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    In latrunculin B-treated Sf9 cells, inter-microtubule distances were greater in Tau 3D-expressing cells than in Tau WT- or Tau 3A-expressing cells (mean 37.1 nm vs 26.8 and 27.2 nm).

    “The inter-MT distances were greater in Tau 3Doverexpressing cells compared to those overexpressing WT or 3A (Fig. 7L).”
    • Also stated in: § The phosphorylation mimic Tau 3D increases MT spacing in processes of Sf9 cells · plain
      “that range was 35-45 nm in Tau 3D-expressing cells (mean distance ϭ 37.1 Ϯ 2.3 nm)”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    Tau overexpression reduced the velocity of mitochondria in axons of cortical neurons.

    “Tau overexpression also reduced the velocity of mitochondria in axons.”
    • Also stated in: § Tau phosphorylation reduces mitochondrial motility in neuritic processes of PC12 cells · plain
      “The mean anterograde and retrograde velocities were 0.55 Ϯ 0.08 and 0.45 Ϯ 0.03 m/s, respectively, in control cells, but they were reduced to 0.17 Ϯ 0.03 and 0.18 Ϯ 0.06 m/s in Tau WT-overexpressing neurons, 0.18 Ϯ 0.03 and 0.19 Ϯ 0.07 m/s in Tau 3A-overexpressing neurons, and 0.18 Ϯ 0.03 and 0.18 Ϯ 0.04 m/s in Tau 3Doverexpressing neurons.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing). The quote only partly states this claim.

    Findingown data

    In cortical neurons, velocities faster than 1 μm/s were not observed in any Tau-overexpressing neurons.

    “Velocities faster than 1 m/s, which accounted for 15 and 11% of anterograde and retrograde movements, respectively, in control neurons, were not observed in any Tau-overexpressing neurons.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In vitro, inter-microtubule distances in microtubule pellets polymerized with Tau WT, 3A, and 3D were typically less than 10 nm, indicating that the phosphorylation-mimicking mutation at AT8 did not affect inter-microtubule spacing in pelleted microtubules.

    “The distances were typically Ͻ10 nm in the MT pellets polymerized with Tau WT, 3A, and 3D (Fig. 7D), indicating that the phosphorylationmimicking mutation at Ser199/Ser202/Thr205 did not affect the inter-MT spacing in pelleted MTs.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In untreated Sf9 cell processes, the mean inter-MT distance was 15.7 ± 2.2 nm for Tau WT, 17.5 ± 2.7 nm for Tau 3A, and 16.3 ± 2.2 nm for Tau 3D.

    “The mean distance was 15.7 Ϯ 2.2 nm for Tau WT (n ϭ 30), 17.5 Ϯ 2.7 nm for Tau 3A (n ϭ 27), and 16.3 Ϯ 2.2 nm for Tau 3D (n ϭ 28).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Phosphorylated Tau 3A and 3D had similar, but not identical, banding patterns, suggesting that these mutants underwent similar phosphorylation at other sites.

    “Phosphorylated Tau 3A and 3D had similar, but not identical, banding patterns, suggesting that these mutants underwent similar phosphorylation at other sites (Fig. 1 D).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingreasoning

    Tau WT had a higher level of phosphorylation than Tau 3A, including at the AT8 site.

    “As a whole, the decreased mobility of Tau WT compared to Tau 3A indicated the higher level of phosphorylation of Tau WT, including the AT8 site.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The ratio of anterogradely moving time to total moving duration was significantly different between control and Tau-overexpressing PC12 cells (p < 0.01), but not significant between the three Tau constructs (p = 0.75).

    “The ratio was significantly different between control and Tau-overexpressing PC12 cells (*p Ͻ 0.01), but was not significant between three Tau constructs ( p ϭ 0.75).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In latrunculin B-treated Sf9 cell processes, the mean inter-MT distance was 26.8 ± 2.7 nm for Tau WT, 27.2 ± 2.0 nm for Tau 3A, and 37.1 ± 2.3 nm for Tau 3D.

    “The mean distance was 26.8 Ϯ 2.7 nm for Tau WT (n ϭ 60), 27.2 Ϯ 2.0 nm for Tau 3A (n ϭ 80), and 37.1 Ϯ 2.3 nm for Tau 3D (n ϭ 75).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Tau phosphorylation at the AT8 sites may have meaningful effects on mitochondrial movement, likely by controlling microtubule spacing.

    “Thus, Tau phosphorylation at the AT8 sites may have meaningful effects on mitochondrial movement, likely by controlling microtubule spacing.”
    • Also stated in: § Discussion · hedged
      “we would like to propose that phosphorylation of Tau at the AT8 sites affects the transport of mitochondria along MTs by changing the inter-MT spaces.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Increased inter-microtubule spacing impairs mitochondrial transport.
  • May combine two claims.

    Premisecitation

    AT8 recognizes Tau phosphorylated at Ser202 and Thr205 or at Ser199, Ser202, and Thr205.

    “AT8, which recognizes Tau that is phosphorylated at Ser202 and Thr205 (Goedert et al., 1995) or Ser199, Ser202, and Thr205 (Hanger et al., 2009).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Goedert et al., 1995 source
    • cites Hanger et al., 2009 source
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    Increased repulsive forces between MTs would generate a stronger reactive resistance against mitochondria moving inside MT bundles.

    “Increased repulsive forces between MTs would generate a stronger reactive resistance against mitochondria moving inside MT bundles.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Phosphorylation at major Ser-Pro/Thr-Pro sites reduces but does not abolish Tau binding to MTs, leading to more dynamic MTs.

    “Phosphorylation at these sites reduces, but does not abolish, Tau binding to MTs, leading to more dynamic MTs (Wada et al., 1998;Liu et al., 2007).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Wada et al., 1998 source
    • cites Liu et al., 2007 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    This would suppress mitochondrial transport along MTs by restricting radial displacement of MTs.

    “This would suppress mitochondrial transport along MTs by restricting radial displacement of MTs.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    The force produced by outward extension of the projection domain may not be strong enough to push surrounding MTs against the membrane, which may explain why phosphorylation-induced expansion of the inter-MT distance has not been reported.

    “The force produced by outward extension of the projection domain may not be strong enough to push surrounding MTs against the membrane, which may explain why phosphorylation-induced expansion of the inter-MT distance has not been reported.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    AT8 reactivity has been frequently used as an indicator of hyperphosphorylation of Tau in AD brains or other tauopathies.

    “AT8 reactivity has been frequently used as an indicator of hyperphosphorylation of Tau in AD brains or other tauopathies (Stoothoff and Johnson, 2005;Hanger et al., 2009).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Stoothoff and Johnson, 2005

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites Hanger et al., 2009 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All experiments were performed at least three times.

    “All experiments were performed at least three times, and representative results are shown.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    According to the paperclip structural model, the site near Ser199/Ser202/Thr205 folds and the N-terminal region is situated close to the MT-binding repeats.

    “According to the paperclip structural model of Tau (Jeganathan et al., 2006), the site near Ser199/Ser202/Thr205 folds and the N-terminal region is situated close to the MT-binding repeats.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Jeganathan et al., 2006 source
  • Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).

    Premisecitation

    Tau impairs mitochondrial movement by inhibiting the interaction of kinesin with microtubules.

    “Tau impairs mitochondrial movement by inhibiting the interaction of kinesin with MTs (Hagiwara et al., 1994).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Hagiwara et al., 1994 source
  • May combine two claims.

    Interpretationown data

    Increased phosphorylation of the AT8 sites in brains of Alzheimer's patients decreases mitochondrial transport in axons, leading to axonal degeneration.

    “Thus, our results suggest that the increased phosphorylation of the AT8 sites in brains of Alzheimer's patients decreases mitochondrial transport in axons, leading to axonal degeneration.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Tau is a phosphoprotein whose functions can be regulated by phosphorylation.

    “Tau is also a phosphoprotein, the functions of which can be regulated by phosphorylation (Stoothoff and Johnson, 2005;Hanger et al., 2009).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Stoothoff and Johnson, 2005

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites Hanger et al., 2009 source
  • May combine two claims.

    Interpretationown data

    Phosphorylation of Tau at the AT8 sites tends to increase the inter-MT distance, but under strong tension the inter-MT distance cannot expand, and instead the repulsive forces between MTs increase.

    “Phosphorylation of Tau at the AT8 sites tends to increase the inter-MT distance, but under strong tension the inter-MT distance cannot expand (Fig. 8), and instead the repulsive forces between MTs increase (Fig. 9).”
    Quote in the paperSubstantial claim
42 of 42
  • The paper relies on this without support.

    Findings from cultured cells and overexpression of Tau mutants generalize to Alzheimer's disease pathophysiology.

    “Hyperphosphorylation of the AT8 sites may contribute to axonal degeneration by disrupting mitochondrial transport in Alzheimer's disease.”
  • The paper relies on this without support.

    Disrupted mitochondrial transport causes axonal degeneration.

    “Hyperphosphorylation of the AT8 sites may contribute to axonal degeneration by disrupting mitochondrial transport in Alzheimer's disease.”
  • The paper relies on this without support.

    Increased inter-microtubule spacing impairs mitochondrial transport.

    “we would like to propose that phosphorylation of Tau at the AT8 sites affects the transport of mitochondria along MTs by changing the inter-MT spaces.”
  • The paper relies on this without support.

    Site-specific functions of Tau phosphorylation have not been completely investigated.

    “However, site-specific functions have not been completely investigated.”
  • The paper relies on this without support.

    Actin filaments are abundant in submembranous regions, providing tension to plasma membranes.

    “Actin filaments are abundant in submembranous regions, providing tension to plasma membranes.”
  • The paper relies on this without support.

    The Ser199/Ser202/Thr205 sites are present in the border between the N-terminal projection region and the MT-binding region.

    “The Ser199/Ser202/Thr205 sites are present in the border between the N-terminal projection region and the MT-binding region.”
6 of 6

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shahpasand, K., Uemura, I., Saito, T., Asano, T., Hata, K., Shibata, K., Toyoshima, Y., Hasegawa, M., & Hisanaga, S.-I.
Affiliations
  • Tokyo Metropolitan University (JP)
  • The University of Tokyo (JP)
  • Tokyo Metropolitan Institute of Medical Science (JP)
Venue
The Journal of Neuroscience
Published
2012-02-14
Volume
32
Issue
7
Pages
2430-2441
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2075421841
Cited by
206
References
67
Citations by year
2026: 10 · 2025: 16 · 2024: 11 · 2023: 18 · 2022: 15 · 2021: 23 · 2020: 16 · 2019: 10 · 2018: 12 · 2017: 9 · 2016: 15 · 2015: 15 · 2014: 16 · 2013: 12 · 2012: 8
FWCI
10.94
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science (23240050)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords
tau phosphorylation, Alzheimer's disease, mitochondrial transport, neurofibrillary tangles, axonal degeneration, phosphomimetic mutations, PC12 cells, cortical neurons, axonal mitochondria
MeSH terms
Alanine, Alzheimer Disease, Animals, Aspartic Acid, Biological Transport, Cells, Cultured, Chlorocebus aethiops, Female, Humans, Male, Microtubules, Mitochondria, Mutation, Phosphorylation, Protein Binding, PC12 Cells, tau Proteins, COS Cells, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review